565. Novel Lentiviral Cell Fate Control Gene Therapy Based on Engineered Variants of the Human Deoxycytidine Kinase

Open Access

https://doi.org/10.1016/s1525-0016(16)39968-3

Copy DOI

Journal: Molecular Therapy	Publication Date: May 1, 2008
License type: cc-by-nc-nd

Abstract

565. Novel Lentiviral Cell Fate Control Gene Therapy Based on Engineered Variants of the Human Deoxycytidine Kinase

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author